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Temporal trends and black–white disparity in
mortality among hospitalized persons living with
HIV in the United States
∗

Hamisu M. Salihu, MD, PhDa,b, , Chelsea Henshaw, BAa, Jason L. Salemi, PhDa,b, Deepa Dongarwar, MSa,
Usman J. Wudil, MD, MPHc, Omonike Olaleye, PhD, MPHd, Nupur Godbole, BSa, Anjali Aggarwal, MDb,
Muktar H. Aliyu, MD, DrPHc,e
Abstract
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We sought to determine whether black–white gap in mortality exists among hospitalized HIV-positive patients in the United States
(US). We hypothesized that in-hospital mortality (IHM) would be similar between black and white HIV-positive patients due to the
nationwide availability of HIV services.
Our analysis was restricted to hospitalized HIV-positive patients (15–49 years). We used the National Inpatient Sample (NIS) that
covered the period from January 1, 2002 to December 31, 2014. We employed joinpoint regression to construct temporal trends in
IHM overall and within subgroups over the study period. We applied multivariable survey logistic regression to generate adjusted
odds ratios (OR) and 95% conﬁdence intervals (CI).
The total number of HIV-related hospitalizations and IHM decreased over time, with 6914 (3.9%) HIV-related in-hospital deaths in
2002 versus 2070 HIV-related in-hospital deaths (1.9%) in 2014, (relative reduction: 51.2%). HIV-related IHM among blacks declined
at a slightly faster rate than in the general population (by 56.8%, from 4.4% to 1.9%). Among whites, the drop was similar to that of the
general population (51.2%, from 3.9% to 1.9%). Although IHM rates did not differ between blacks and whites, being black with HIV
was independently associated with a 17% elevated odds for IHM (OR = 1.17; 95% CI = 1.11–1.25).
In-hospital HIV-related deaths continue to decline among both blacks and whites in the US. Among hospitalized HIV-positive
patients black–white disparity still persists, but to a lesser extent than in the general HIV population. Improved access to HIV care is a
key to eliminating black–white disparity in HIV-related mortality.
Abbreviations: CI = conﬁdence interval, HCUP = Healthcare and Cost Utilization Project, HIV = human immunodeﬁciency virus,
ICD-9-CM = International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation, IHM = in-hospital mortality, NIS = National
Inpatient Sample, OR = odds ratio.
Keywords: antiretroviral therapy, HIV/AIDS, in-hospital mortality, racial disparity, trends

improved survival of HIV-positive individuals.[1–3] The arrival of
highly effective ART regimens resulted in a signiﬁcant increase in
the quantity and quality of life of HIV-positive patients.[3–5] The
number of deaths from HIV-related complications decreased
from an estimated 1.9 million in 2005 to 1.0 million in 2016
worldwide.[6] These advances are attributed to a global effort
crowned by the increased availability of ART and the
accompanying decrease in HIV transmission rates.[7] As of
2017, globally more than 20 million HIV-infected people were
being managed with ART, which represents an astounding
improvement from the 7.7 million people on ART in 2010.[6]
In the United States (US), there were an estimated 38,500 new
HIV infections in 2015, which represented a decline of 8% from
2010 numbers (41,800).[8] Although blacks comprise only 12%
of the general US population, they account for almost half of all
new HIV diagnoses, making them the most HIV-affected racial
group in the US. These trends are also notable in HIV mortality,
with blacks accounting for 52% of HIV-related deaths in 2015.[9]
Previous studies have reported a widening black–white disparity
in mortality within the general population,[10] and a recurring
inﬂuential factor is access to care.[11] We, therefore, sought to
determine whether the widening black–white gap was observable
among hospitalized HIV patients with access to care. We
hypothesized that in-hospital mortality (IHM) would be similar
between black and white HIV-positive patients as a result of
availability of care. To reduce the impact of co-morbidity that

1. Introduction
With the advent of combination antiretroviral therapy (ART) in
the 1990s, a notable decline in opportunistic infections led to
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periods in time that characterize changes in the rate of events over
time.[13,14] The iterative model-building process was initiated by
ﬁtting the yearly rate data to a straight line with no joinpoints,
which assumed a single trend that best described the data points.
A joinpoint—reﬂecting a change in the trend—was then added to
the model. A Monte Carlo permutation test assessed the
improvement in model ﬁt. The process continued until a ﬁnal
model with an optimal (best-ﬁtting) number of joinpoints was
selected, with each joinpoint indicating a change in the trend. An
annual percent change was estimated to characterize how the rate
changed within each distinct trend segment.
We calculated descriptive statistics, including rates, percentages, and ratios to analyze the relationship between patient
characteristics and mortality outcomes. We employed multivariable survey logistic regression to generate adjusted odds ratios
(OR) that quantiﬁed the magnitude of the association between
exposure status (race) and mortality among HIV-positive
patients. Statistical analyses were performed with SAS, version
9.4 (SAS Institute, Inc., Cary, NC); we assumed a 5% type I error
rate for all hypothesis tests (2-sided). This study was approved as
exempt by the Baylor College of Medicine Institutional Review
Board.

tends to rise and be disproportionate with age, we restricted our
analysis to hospitalized HIV-infected patients within the age
bracket of 15 to 49 years.

2. Materials and methods
We analyzed data that contained publically-available information on US hospital discharges from January 1, 2002 to December
31, 2014 using the National Inpatient Sample (NIS). The
compilation of the NIS database was implemented by the
Healthcare and Cost Utilization Project (HCUP) which makes it
available to researchers on an annual basis. The data was
collected from participating nonfederal community hospitals
throughout the country stratiﬁed by 5 characteristics: rural/urban
location, number of beds, geographic region, teaching status, and
ownership. Using a systematic sampling technique, 20% of the
hospitals from each stratum were randomly selected to ensure
geographic representativeness.[12] As from the year 2012, this
technique was modiﬁed to permit sample gathering from all
participating hospitals. After a hospital was sampled, all inpatient
hospitalization records for the facility were then captured in the
NIS database. Further, HCUP provides discharge-level sampling
weights so that national frequency and prevalence estimates will
account for the 2-stage cluster sampling design. The NIS contains
approximately 7 million inpatient hospitalizations each year
(equivalent to 36 million when weighted) and the number has
progressively grown as other states join the consortium.
For the purpose of this study, we restricted the study
population to hospitalized individuals (15–49 years) with a
positive diagnosis of HIV. To identify these patients, we scanned
International Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation (ICD-9-CM) codes (the principal diagnosis and up
to 24 secondary diagnoses) in each patient’s discharge record for
an indication of any one of the following ICD-9 codes:

3. Results
In total, 56,203 (2.9%) cases of IHM due to HIV were reported
over the study period (2002 through 2014). The total number of
HIV-related hospitalizations and HIV-related in-hospital deaths
decreased progressively over time, with 6914 (3.9%) HIV-related
in-hospital deaths in 2002 versus 2070 HIV-related in-hospital
deaths (1.9%) in 2014. The proportion of HIV-positive men
(3.1%) who died was higher than that of HIV-positive women
(2.5%) during the entire period, with slightly more non-Hispanic
blacks (2.9%) dying than non-Hispanic whites (2.7%). Similarly,
more deaths occurred among non-Hispanic black men (3.2%)
and women (2.6%) than in non-Hispanic white men (2.9%) and
women (2.3%). The overall IHM was similar between black and
white women (2.6% vs 2.3%, respectively P >.05.
Figure 1 compares temporal trends in IHM among HIVpositive patients in the US for whites versus blacks. In the entire
HIV-positive population as well as within the 2 racial categories,
there was a signiﬁcant reduction in IHM. The IHM rate dropped
signiﬁcantly over the study period, from 3.9% to 1.9%,
equivalent to a relative reduction of 51.2%. There was a
56.8% decrease in IHM among blacks (from 4.4% to 1.9%),
while among whites, the drop was 51.2% (from 3.9% to 1.9%),
similar to that of the entire population. There was no statistically
signiﬁcant difference in annual percent change in IHM between
the 2 racial groups.
We further explored racial disparity by sex separately with
respect to temporal trends. The results are shown in Figure 2a (for
men) and Figure 2b (for women). Among men, the IHM rate for
whites dropped from 3.6% to 1.9% by the end of the study
period, equivalent to a 47.2% decline. The greatest decline was
among black men and women (by 57.4% and 56.1%,
respectively), while the lowest decline was noted among white
women, who experienced a drop of only 16.7% in IHM.
Although both black men and women had markedly elevated
levels of IHM at the beginning of the study period (4.7% and
4.1% compared to 3.6% and 2.4% for whites respectively),
mortality for black women was the lowest by the end of the study
(1.8%). The reduction in IHM did not demonstrate statistically
signiﬁcant black–white differences when stratiﬁed by sex.

a) 042: human immunodeﬁciency virus (HIV) disease;
b) 079.53: HIV, type 2 (HIV-2); and
c) V08: asymptomatic HIV infection status.
Individual-level socio-demographic factors reported in the NIS
database were extracted and included in the analysis. Age in years
was classiﬁed into 3 categories: 15 to 24, 25 to 34, and 35 to 49.
Self-reported race and ethnicity data were collected under the
classiﬁcation of Non-Hispanic white, Non-Hispanic black,
Hispanic, or other, but we limited the dataset to only blacks
and whites non-Hispanics. Median household income was
classiﬁed into quartiles based on the patient’s zip code, serving
as a proxy for socioeconomic status. Primary insurance payers
were grouped into 3 categories: government (Medicare/Medicaid), private (commercial carriers, health maintenance organizations, and preferred provider organizations), and other (self-pay,
charity, etc). Hospital characteristics were also considered,
including US census region (Northeast, Midwest, South, or
West) and hospital type (rural, urban teaching, or urban nonteaching). In-hospital death was the main outcome considered in
the study. In-hospital death was deﬁned as a documented
disposition of “expired”, indicating death before hospital
discharge.
2.1. Statistical analysis
We employed joinpoint regression to construct the temporal
trends in IHM for the period of the study overall, as well as within
subgroups. Joinpoint regression is of utility in deﬁning key
2
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Figure 1. Temporal trends in the prevalence of in-hospital mortality (per 1000 hospitalizations) among HIV-positive men and women, overall and by race/ethnicity,
United States, 2002 to 2014. APC = annual percent change; NH = non-Hispanic.

likelihood of death compared to HIV-positive men (adjusted OR,
aOR = 0.82, 95% conﬁdence interval [CI] = 0.78 - 0.85), while
black patients had a 17% greater odds of death than their white
counterparts (aOR = 1.17, 95% CI = 1.11–1.25). Patients covered by public health insurance exhibited lower odds of mortality

Table 1 summarizes the predictors of IHM among HIVpositive individuals in the US. Age of the patient was predictive of
mortality, with older individuals having between 50% to 90%
greater odds of mortality in a dose-response pattern (i.e.,
increasing odds with age). HIV-positive women had a 18% lower

Figure 2. A, B. Temporal trends in the prevalence of in-hospital mortality (per 1000 hospitalizations) among HIV-positive men and HIV-positive women, overall and
by race/ethnicity, United States, 2002 to 2014. APC = annual percent change; NH = non-Hispanic.
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of mortality (aOR = 0.79, 95% CI = 0.69–0.92). Public insurance
coverage, residence in the southern US, small hospital bed size
and urban hospital location were signiﬁcant predictors of IHM
among HIV-positive black women, but not their white counterparts (Table 3). Weekend admission was predictive of mortality
in both black and white women.

Table 1
Predictors of in-hospital mortality among hospitalized HIV-positive
patients in the United States, 2002 to 2014.
Characteristic
Age
15–24
25–34
35–49
Gender
Male
Female
Race
NH White
NH Black
Household Income
Lowest
2nd
3rd
Highest
Insurance
Private
Public
Other
Admission Day
Weekday
Weekend
Hospital Region
Northeast
Midwest
South
West
Hospital Bedsize
Small
Medium
Large
Hospital Type
Rural
Urban, non-teaching
Urban, teaching
∗
†

∗

Crude OR (95% CI)

Adjusted OR (95% CI)

Ref†
∗
1.68 (1.48, 1.90)
∗
1.91 (1.70, 2.15)

Ref
∗
1.57 (1.39, 1.78)
∗
1.88 (1.67, 2.11)

Ref
∗
0.79 (0.76, 0.83)

Ref
∗
0.82 (0.78, 0.85)

Ref
∗
1.07 (1.01, 1.13)

Ref
∗
1.17 (1.11, 1.25)

0.97 (0.90, 1.05)
0.96 (0.89, 1.04)
0.94 (0.87, 1.02)
Ref

1.01 (0.94, 1.09)
0.98 (0.91, 1.06)
0.95 (0.87, 1.04)
Ref

Ref
∗
0.88 (0.82, 0.94)
1.03 (0.94, 1.12)

Ref
∗
0.89 (0.83, 0.95)
1.01 (0.93, 1.11)

Ref
∗
1.15 (1.10, 1.21)

1.15 (1.10, 1.20)

Ref
∗
0.85 (0.76, 0.94)
∗
1.26 (1.16, 1.38)
∗
1.48 (1.33, 1.64)

Ref
∗
0.81 (0.71, 0.91)
∗
1.23 (1.12, 1.36)
∗
1.39 (1.24, 1.54)

∗

4. Discussion
In this large nationwide study on racial disparity in mortality
among hospitalized HIV-positive young individuals, we found a
51.2% reduction in IHM over the period 2002 to 2014. The
magnitude of the reduction in IHM over the study period was
similar for whites and for blacks (51.2% vs 56.8%, respectively).
However, despite this signiﬁcant and appreciable reduction in
IHM in both racial groups, adjustment for potential confounders
revealed that HIV-positive blacks were 17% more likely to
experience death following hospital admission when compared to
their white counterparts. Previous studies based on national vital
records reported widening of HIV-related black-white mortality
gap when the mortality rates for the period 1990 to 1994 were
compared to those for the period 2005 to 2009.[10] One major
difference between that study and ours is that we restricted our
analysis to IHM. Secondly, we examined mortality among a
relatively younger population (15–49 years) with greater life
expectancy than for the general population, and within which
black young adults exhibit more than twice the mortality risk of
their white counterparts.[15–18] Our ﬁndings could, therefore, be
an indication that the level of HIV-related black-white gap in
mortality among hospitalized patients exposed to supervised
management within hospital institutions was lower than that of
the general population of HIV patients. Access to care is,
therefore, a major factor that could explain previously reported
widening black-white disparity in the HIV general population.
The availability of care within the hospital setting provides
an avenue for HIV-related health challenges to be properly
addressed, including diagnosis of HIV infection, linkage to care,
retention in care, receipt of antiretroviral therapy, achievement of
viral suppression and management of HIV co-morbidities, such
as tuberculosis.[19,20] Since whites attain viral suppression better
than blacks,[21] HIV-related IHM would be expectedly lower
among whites, as observed in this study. However, our analysis in
this regard was weakened by the lack of information on HIV viral
load as well as other biologic predictors of survival.
The black-white disparity in IHM within this study could be
explained by non-biologic factors related to quality of care upon
hospitalization, pre-hospitalization anti-retroviral therapy (ART)
uptake and adherence since these parameters inﬂuence HIV
morbidity and mortality. HIV-positive black people are less
likely to adhere to medical appointments and to achieve HIV
suppression.[22,23] The decreased likelihood of optimal HIV
disease control before hospitalization and the elevated risk for
disease progression may be a plausible explanation for the 17%
increment in mortality after adjustment for other factors. It is also
reasonable to suggest that inequity in accessing quality care
by HIV-positive individuals even during admission could be a
contributory factor.
As in previous studies,[24] we found disparity in mortality in
relation to place of residence. We observed that living in the
southern US was associated with elevated risk of mortality during
hospitalization among black, but not white HIV-positive
patients. Previous studies did report that HIV-infected people
residing in the US South experienced worse outcomes in general

∗

∗

0.86 (0.77, 0.95)
1.01 (0.93, 1.10)
Ref

0.88 (0.80, 0.97)
1.01 (0.93, 1.09)
Ref

1.12 (0.97, 1.29)
∗
1.13 (1.05, 1.22)
Ref

1.08 (0.94, 1.24)
1.06 (0.99, 1.14)
Ref

CI = conﬁdence interval, OR = odds ratio.
ref = referent category.

compared to those on private health insurance (aOR = 0.88, 95%
CI = 0.83–0.95. Individuals living in the Western and Southern
US also demonstrated greater odds for death than those living in
the Northeast. There was no association between IHM on the
one hand, and household income, hospital size, and urban/rural
hospital location.
In Table 2, we examined the same predictors stratiﬁed by race/
ethnicity, that is, separate analysis for non-Hispanic blacks and
non-Hispanic whites. Similar results were obtained for both
racial groups as for the entire group with respect to age, sex,
household income, and urbanicity. The elevated odds of IHM for
HIV-positive patients residing in the Southern US was particularly remarkable among blacks, while their white counterparts
did not experience signiﬁcant risk elevation.
Since sex could play an important role either as a confounder
or a mediator for the black–white disparity in mortality, we
generated the same results for men and for women separately.
Among HIV-positive men (Table 3), black-white differences in
predictors of mortality were observed in regards to health
insurance, weekend admission, and hospital size. Whereas public
health insurance was protective of mortality, weekend admission
was a risk factor for mortality among white men only. Among
black men only, small hospital size signiﬁcantly reduced the odds
4
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Table 2
Predictors of in-hospital mortality among HIV-positive blacks and whites (men and women), 2002 to 2014.
Characteristic
Age
15–24
25–34
35–49
Gender
Male
Female
Income
Lowest
2nd
3rd
Highest
Household Insurance
Private
Public
Other
Admission Day
Weekday
Weekend
Hospital Region
Northeast
Midwest
South
West
Hospital Bedsize
Small
Medium
Large
Hospital Type
Rural
Urban, non-teaching
Urban, teaching
∗
†

Crude OR (95% CI)

∗

Blacks

Whites
Adjusted OR (95% CI)

Crude OR (95% CI)

Adjusted OR (95% CI)

Ref†
∗
1.60 (1.36, 1.89)∗
1.83 (1.57, 2.13)

Ref
∗
1.51 (1.28, 1.78)∗
1.81 (1.55, 2.11)

Ref
∗
1.93 (1.34, 2.78)∗
2.40 (1.69, 3.39)

Ref
∗
1.83 (1.27, 2.63)∗
2.30 (1.62, 3.25)

Ref
∗
0.83 (0.78, 0.87)

Ref
∗
0.84 (0.80, 0.89)

Ref
∗
0.79 (0.72, 0.87)

Ref
∗
0.86 (0.78, 0.95)

0.95 (0.85, 1.06)
0.93 (0.83, 1.05)
0.88 (0.76, 1.00)
Ref

1.00 (0.90, 1.12)
0.96 (0.85, 1.08)
0.90 (0.78, 1.03)
Ref

0.98 (0.87, 1.11)
0.96 (0.84, 1.08)
1.01 (0.88, 1.15)
Ref

1.03 (0.91, 1.18)
1.00 (0.87, 1.14)
1.04 (0.91, 1.19)
Ref

Ref
∗
0.89 (0.80, 0.98)
1.02 (0.91, 1.16)

Ref
∗
0.89 (0.80, 0.98)
0.99 (0.88, 1.12)

Ref
∗
0.87 (0.79, 0.96)
1.02 (0.89, 1.16)

Ref
∗
0.89 (0.81, 0.98)
1.05 (0.91, 1.21)

Ref
∗
1.15 (1.08, 1.22)

Ref
1.14 (1.07, 1.21)∗

Ref
∗
1.19 (1.09, 1.30)

Ref
∗
1.19 (1.09, 1.31)

Ref
∗
0.85 (0.73, 1.00)∗
1.33 (1.19, 1.49)∗
1.46 (1.23, 1.72)

Ref
∗
0.80 (0.68, 0.95)∗
1.28 (1.12, 1.45)∗
1.34 (1.12, 1.59)

Ref
0.92 (0.77, 1.09)∗
1.12 (1.00, 1.26)∗
1.36 (1.20, 1.55)

Ref
0.88 (0.73, 1.06)
1.11 (0.98, 1.25)
1.28 (1.12, 1.47)∗

0.89 (0.75, 1.05)
1.00 (0.90, 1.12)
Ref

0.92 (0.77, 1.09)
1.01 (0.90, 1.14)
Ref

0.90 (0.74, 1.08)
1.02 (0.92, 1.12)
Ref

0.92 (0.76, 1.12)
0.98 (0.89, 1.09)
Ref

0.76 (0.66, 0.88)
0.99 (0.87, 1.12)
Ref

∗

0.77 (0.68, 0.88)
0.99 (0.88, 1.11)
Ref

∗

∗

1.19 (0.95, 1.49)
1.10 (0.99, 1.21)
Ref

1.34 (1.05, 1.69)∗
1.19 (1.07, 1.32)
Ref

CI = conﬁdence interval, OR = odds ratio.
ref = referent category.

Table 3
Predictors of in-hospital mortality among HIV-positive blacks and whites (men and women), 2002 to 2014.
Men
Characteristic
Age
15–24
25–34
35–49
Household Income
Lowest
2nd
3rd
Highest
Insurance
Private
Public
Other
Admission Day
Weekday
Weekend
Hospital Region
Northeast
Midwest
South
West
Hospital Bedsize
Small
Medium
Large
Hospital Type
Rural
Urban, non-teaching
Urban, teaching
∗
†

Women

Blacks
∗
adjusted OR (95% CI)

Whites
adjusted OR (95% CI)

Black
adjusted OR (95% CI)

Whites
adjusted OR (95% CI)

Ref†
∗
1.36 (1.10, 1.69)∗
1.55 (1.26, 1.89)

Ref
∗
2.92 (1.66, 5.15)∗
3.37 (1.93, 5.88)

Ref
∗
1.67 (1.29, 2.15)∗
2.15 (1.70, 2.73)

Ref
1.02 (0.63, 1.67)∗
1.70 (1.08, 2.67)

1.04 (0.90, 1.18)
1.00 (0.86, 1.16)
0.91 (0.77, 1.08)
Ref

1.04 (0.90, 1.19)
0.97 (0.83, 1.12)
1.00 (0.86, 1.16)
Ref

0.95 (0.80, 1.13)
0.89 (0.74, 1.06)
0.87 (0.71, 1.07)
Ref

1.04 (0.78, 1.39)
1.12 (0.84, 1.49)
1.20 (0.90, 1.62)
Ref

Ref
0.92 (0.81, 1.03)
1.01 (0.88, 1.16)

Ref
∗
0.86 (0.78, 0.96)
1.04 (0.89, 1.22)

Ref
∗
0.86 (0.74, 0.98)
0.96 (0.79, 1.15)

Ref
1.02 (0.79, 1.31)
1.09 (0.77, 1.54)

Ref
1.07 (0.99, 1.16)

Ref
∗
1.17 (1.06, 1.30)

Ref
∗
1.24 (1.13, 1.36)

Ref
∗
1.29 (1.06, 1.56)

Ref
∗
0.78 (0.63, 0.96)∗
1.27 (1.10, 1.47)∗
1.30 (1.07, 1.59)

Ref
0.92 (0.75, 1.13)∗
1.19 (1.03, 1.38)∗
1.32 (1.13, 1.55)

Ref
0.84 (0.67, 1.06)∗
1.28 (1.10, 1.48)∗
1.45 (1.10, 1.91)

Ref
0.81 (0.58, 1.14)
0.91 (0.75, 1.11)
1.33 (0.99, 1.78)

0.97 (0.80, 1.18)
1.01 (0.89, 1.15)
Ref

0.73 (0.61, 0.88)
1.01 (0.88, 1.16)
Ref

0.94 (0.75, 1.18)
0.98 (0.87, 1.10)
Ref

1.30 (0.99, 1.71)∗
1.24 (1.09, 1.40)
Ref

0.79 (0.69, 0.92)
0.98 (0.86, 1.11)
Ref
1.11 (0.86, 1.43)
1.01 (0.90, 1.13)
Ref

∗

CI = conﬁdence interval, OR = odds ratio.
ref = referent category.
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∗

0.76 (0.54, 1.07)
1.02 (0.85, 1.23)
Ref
0.87 (0.60, 1.28)
0.98 (0.82, 1.17)
Ref
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than those living in other geographical regions of the US.[25]
Research has shown that the US South bears the highest agestandardized HIV mortality rates and the highest age-standardized HIV case fatality rates.[26] This geographical disparity may
be explained by the preponderance of HIV infections in the US
South, as well as adverse health outcomes among HIV-positive
individuals intimately linked to unfavorable institutional policies
in many southern states, including refusal to broaden opportunities for low-income earners to have access to healthcare (e.g.,
through Medicaid expansion) and the high rates of incarceration
in these states that disproportionately affect blacks.[11] These
factors represent a huge barrier to achieving virologic suppression among HIV-positive US black southerners, making them
sicker and more likely to die during hospitalization.[27]
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Olaleye, Nupur Godbole, Anjali Aggarwal, Muktar Hassan
Aliyu.
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Olaleye, Muktar Hassan Aliyu.
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Anjali Aggarwal, Muktar Hassan Aliyu.
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Validation: Hamisu M. Salihu, Chelsea Henshaw, Jason L.
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Writing - review & editing: Hamisu M. Salihu, Chelsea
Henshaw, Jason L. Salemi, Deepa Dongarwar, Usman J.
Wudil, Nupur Godbole, Anjali Aggarwal, Muktar Hassan
Aliyu.

4.1. Limitations
A limitation in the data we analyzed is the absence of information
regarding quality of HIV care or stratiﬁcation of outcomes by
treatment cascade, which is an outline of the essential steps to
viral suppression and therefore, reduction of mortality risk. These
steps encompass diagnosis of HIV (and whether delayed or not),
linkage to care, retention in care, receipt of ART, and
achievement of viral suppression.[28] Other important data that
could have impacted our analysis but were absent in the dataset
included HIV disease severity, types of treatment received, level of
HIV viral load during the phase of hospital admission and social
support systems. Nonetheless, this study has merits, including a
large study population sample, gathered nationwide, making our
ﬁndings generalizable. To our knowledge, this is the ﬁrst study
that examined black-white disparity in IHM among HIV-positive
patients in the US, and the results represent new ﬁndings that
could be of utility to policy makers and HIV care providers in
general.
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